Medical weight loss is weight management led by a licensed prescriber, who can add FDA-approved medicine such as semaglutide to diet and activity changes.
Starting with cost
Tucson's median household income is $57,073 [3]. At manufacturer self-pay prices, a year of the lowest-dose Foundayo or Wegovy pill at $149 a month is $1,788, about 3.1% of that income; a year of the Wegovy pen at $349 is $4,188, about 7.3% [4] [5]. Most people move up from starting doses, and higher pill doses cost $299 a month [5]. Clinic fees come on top.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Tucson, from $300 a month.
Ads in the sponsored box are paid for and labeled, and we do not endorse them. Details: sponsor a city.
Semaglutide in Tucson
Semaglutide goes by two brand names: Wegovy for weight and Ozempic for type 2 diabetes, and Ozempic is not approved for weight loss [6]. Wegovy is available as a once-weekly pen or a once-daily pill [7]. In STEP 1, adults on 2.4 mg lost 14.9% of body weight on average by week 68, against 2.4% on placebo [8]. With 11.0% of Pima County adults diagnosed with diabetes [1], some Tucson patients may qualify for Ozempic through insurance instead. More: semaglutide, semaglutide cost.
| Brand and form | Tucson buyer pays | Ref |
|---|---|---|
| Foundayo, daily tablet | $149 to $299 | [4] |
| Wegovy, daily tablet | $149 to $299 | [5] |
| Wegovy, weekly pen | $349 a month; $199 each for a newcomer's first two low-dose boxes | [5] |
| Zepbound, weekly injection | $299 to $449 | [9] |
Coverage in Arizona
Arizona does not appear on KFF's January 2026 list of 13 Medicaid programs that pay for obesity GLP-1s [2]. Medicare is a different story for the 16.2% of Tucson residents who are 65 or older [3]: a Part D member who meets the BMI rules pays $50 a month through the GLP-1 Bridge, which runs until December 31, 2027 and covers Wegovy, Foundayo or the Zepbound KwikPen [10]. More on insurance and Medicare coverage.
Cheap offers to question
Very low online prices usually mean compounded semaglutide, which has no FDA approval and gets no FDA review for safety, effectiveness or quality. FDA counted 990 adverse event reports for compounded semaglutide by May 31, 2026, and says it knows of no lawful basis for compounding with the salt forms semaglutide sodium and acetate [11]. Look up the prescriber with the Arizona Medical Board [12]; background is on compounded semaglutide.
Finding care
We found no Tucson hospital weight program with a posted price. Start with the clinic checklist, the medical weight loss guide or where to get semaglutide. Other desert cities: Phoenix, Scottsdale, San Diego and Las Vegas.
Before the first dose
The Wegovy label lists pancreatitis, so belly pain that is intense and lasting needs a doctor [7]. Facial or throat swelling can signal an allergic reaction. Blood sugar can drop too low when insulin or a sulfonylurea is also taken. Thyroid C-cell tumors in rodents led to a boxed warning, which means no use with MEN 2 or with medullary thyroid carcinoma in you or your family. Wegovy should be stopped once a pregnancy is known. For an emergency, dial 911.
Questions people ask
What does semaglutide cost in Tucson without insurance?
On Oct 17, 2026, NovoCare charged $149 to $299 a month for the Wegovy pill and $349 for the Wegovy pen [5].
Why are Tucson obesity numbers for Pima County, not the city?
City-level data was not available to us. CDC PLACES estimates 31.1% of Pima County adults had obesity in 2023 [1].
Does Arizona Medicaid pay for semaglutide for weight loss?
No. Arizona was not among the 13 Medicaid programs KFF found covering obesity GLP-1s in January 2026 [2].
What share of a Tucson household budget would a GLP-1 take?
Are the cheap compounded semaglutide offers aimed at Tucson buyers FDA-approved?
No. Compounded semaglutide is not FDA-approved, and FDA had 990 adverse event reports tied to it as of May 31, 2026 [11].
Sources
12 cited
- PLACES data, county, 2025 release: Pima County, AZ. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- QuickFacts: Tucson city, Arizona. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Foundayo self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Ozempic label. DailyMed, National Library of Medicine, May 2026.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine (PubMed), 2021.
- Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), accessed 2026-10-17.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- Arizona Medical Board. State of Arizona, accessed 2026-10-17.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.